Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5496)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2014 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Kanizaj TF, Kunac N. |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v20/i3/699.htm |
| Number | Citing Articles |
| 1 |
Anthony O'Connor, Takahisa Furuta, Javier P. Gisbert, Colm O'Morain. Review – Treatment of Helicobacter pylori infection 2020. Helicobacter 2020; 25(S1) doi: 10.1111/hel.12743
|
| 2 |
Yanqiang Huang, Xudong Hang, Xueqing Jiang, Liping Zeng, Jia Jia, Yong Xie, Fei Li, Hongkai Bi.
In Vitro
and
In Vivo
Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori
. Antimicrobial Agents and Chemotherapy 2019; 63(6) doi: 10.1128/AAC.00004-19
|
| 3 |
Galit H. Frydman, Nick Davis, Paul L. Beck, James G. Fox. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter 2015; 20(4): 239 doi: 10.1111/hel.12200
|
| 4 |
Mohamed M.M. Abdel-Latif, Mekky M. Abouzied. Molecular Mechanisms of Natural Honey Against H. pylori Infection Via Suppression of NF-κB and AP-1 Activation in Gastric Epithelial Cells. Archives of Medical Research 2016; 47(5): 340 doi: 10.1016/j.arcmed.2016.09.002
|
| 5 |
Youhua Wang, Rulin Zhao, Ben Wang, Qiaoyun Zhao, Zhen Li, Liya Zhu-ge, Wenzhu Yin, Yong Xie. Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis. European Journal of Clinical Pharmacology 2018; 74(1): 1 doi: 10.1007/s00228-017-2347-7
|
| 6 |
Vasiliy Ivanovich Reshetnyak, Alexandr Igorevich Burmistrov, Igor Veniaminovich Maev. <i>Helicobacter pylori</i>: Commensal, symbiont or pathogen? . World Journal of Gastroenterology 2021; 27(7): 545-560 doi: 10.3748/wjg.v27.i7.545
|
| 7 |
Tássia Flores Rech, Luiz Edmundo Mazzoleni, Felipe Mazzoleni, Carlos Fernando de Magalhães Francesconi, Guilherme Becker Sander, Rafael Tomoya Michita, Débora Dreher Nabinger, Tobias Cancian Milbradt, Ronaldo João Spinato Torresini, Daniel Simon. Helicobacter pylori eradication: influence of interleukin-1beta –31 C/T polymorphism. The Brazilian Journal of Infectious Diseases 2018; 22(4): 311 doi: 10.1016/j.bjid.2018.06.005
|
| 8 |
|
| 9 |
Muhammad Arif, Quan-Jiang Dong, Mazhar Ali Raja, Shah Zeenat, Zhe Chi, Chen-Guang Liu. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori. Materials Science and Engineering: C 2018; 83: 17 doi: 10.1016/j.msec.2017.08.038
|
| 10 |
|
| 11 |
Zi-Wei Jing, Yi-Yang Jia, Ning Wan, Min Luo, Meng-Lei Huan, Tai-Bin Kang, Si-Yuan Zhou, Bang-Le Zhang. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori. Biomaterials 2016; 84: 276 doi: 10.1016/j.biomaterials.2016.01.045
|
| 12 |
Priscila Baptistella Yazbek, Ariane Biolcati Trindade, Chung Man Chin, Jean Leandro dos Santos. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori. Digestive Diseases and Sciences 2015; 60(10): 2901 doi: 10.1007/s10620-015-3712-y
|
| 13 |
Jingdong Rao, Yuhe Yang, Ho Pan Bei, Chak-Yin Tang, Xin Zhao. Antibacterial nanosystems for cancer therapy. Biomaterials Science 2020; 8(24): 6814 doi: 10.1039/D0BM01537G
|
| 14 |
Hirotaka Igarashi, Shingo Maeda, Koichi Ohno, Ayako Horigome, Toshitaka Odamaki, Hajime Tsujimoto, Bryan A. White. Effect of Oral Administration of Metronidazole or Prednisolone on Fecal Microbiota in Dogs. PLoS ONE 2014; 9(9): e107909 doi: 10.1371/journal.pone.0107909
|
| 15 |
|
| 16 |
Tsung-Jung Lin, Hsi-Chang Lee, Chih-Lin Lin, Chung-Kwe Wang, Kuan-Yang Chen, Deng-Chyang Wu. CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for <i>Helicobacter pylori</i> eradication. World Journal of Clinical Cases 2018; 6(12): 514-520 doi: 10.12998/wjcc.v6.i12.514
|
| 17 |
Hassan Ali Metanat, Seyed Mohammad Valizadeh, Hafez Fakheri, Iradj Maleki, Tarang Taghvaei, Vahid Hosseini, Zohreh Bari. Comparison Between 10‐ and 14‐Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial. Helicobacter 2015; 20(4): 299 doi: 10.1111/hel.12202
|
| 18 |
Varocha Mahachai, Ratha‐korn Vilaichone, Rapat Pittayanon, Jarin Rojborwonwitaya, Somchai Leelakusolvong, Monthira Maneerattanaporn, Peranart Chotivitayatarakorn, Sombat Treeprasertsuk, Chomsri Kositchaiwat, Pises Pisespongsa, Pisaln Mairiang, Aziz Rani, Alex Leow, Swe Mon Mya, Yi‐Chia Lee, Sengdao Vannarath, Bouachanh Rasachak, Oung Chakravuth, Moe Myint Aung, Tiing‐Leong Ang, Jose D Sollano, Duc Trong Quach, Inchaya Sansak, Olarn Wiwattanachang, Piyathida Harnsomburana, Ari Fahrial Syam, Yoshio Yamaoka, Kwong‐Ming Fock, Khean‐Lee Goh, Kentaro Sugano, David Graham. Helicobacter pylori management in ASEAN: The Bangkok consensus report. Journal of Gastroenterology and Hepatology 2018; 33(1): 37 doi: 10.1111/jgh.13911
|
| 19 |
Ayman Fathy El Sayed, Ayman Magd Eldin Mohammad Sadek, Walid Ahmed Ragab Abdelhamid. Comparison between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Trial. Middle East Journal of Digestive Diseases 2021; 13(3): 223 doi: 10.34172/mejdd.2021.229
|
| 20 |
Nuno Almeida, Maria Manuel Donato, José Manuel Romãozinho, Cristina Luxo, Olga Cardoso, Maria Augusta Cipriano, Carol Marinho, Alexandra Fernandes, Carlos Calhau, Carlos Sofia. Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0245-y
|
| 21 |
María Teresa Orta de Velásquez, Isaura Yáñez Noguez, Beatriz Casasola Rodríguez, Priscila Ivette Román Román. Effects of ozone and chlorine disinfection on VBNCHelicobacter pyloriby molecular techniques and FESEM images. Environmental Technology 2017; 38(6): 744 doi: 10.1080/09593330.2016.1210680
|
| 22 |
Annika Flint, Alain Stintzi, Lígia M. Saraiva, Michael Bott. Oxidative and nitrosative stress defences ofHelicobacterandCampylobacterspecies that counteract mammalian immunity. FEMS Microbiology Reviews 2016; 40(6): 938 doi: 10.1093/femsre/fuw025
|
| 23 |
|
| 24 |
Yong Hwan Kwon, Seong Woo Jeon, Su Youn Nam, Hyun Suk Lee, Ji Hey Park. Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single‐center prospective pilot study. Helicobacter 2019; 24(4) doi: 10.1111/hel.12585
|
| 25 |
Zi-Wei Jing, Min Luo, Yi-Yang Jia, Chen Li, Si-Yuan Zhou, Qi-Bing Mei, Bang-Le Zhang. Anti-Helicobacter pylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative. International Journal of Biological Macromolecules 2018; 115: 367 doi: 10.1016/j.ijbiomac.2018.04.070
|
| 26 |
Wen-Ting Zhou, Yuan-Yuan Dai, Li-Juan Liao, Shi-Xian Yang, Hao Chen, Liang Huang, Juan-Li Zhao, Yan-Qiang Huang. Linolenic acid-metronidazole inhibits the growth of <i>Helicobacter pylori</i> through oxidation. World Journal of Gastroenterology 2023; 29(32): 4860-4872 doi: 10.3748/wjg.v29.i32.4860
Abstract(304) |
Core Tip(340) |
Full Article(HTML)(1195)
|
Full Article with Cover (PDF)-11402K(58)
|
Full Article (Word)-3725K(32)
|
Audio-1140K(2)
|
Peer-Review Report-205K(22)
|
Answering Reviewers-111K(26)
|
Full Article (PDF)-11156K(96)
|
Full Article (XML)-84K(24)
|
Times Cited (1)
|
Total Visits (3981)
|
Open
|